These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21958512)

  • 1. Computerized texture analysis of atypical immature myeloid precursors in patients with myelodysplastic syndromes: an entity between blasts and promyelocytes.
    Vido JR; Adam RL; Lorand-Metze IG; Metze K
    Diagn Pathol; 2011 Sep; 6():93. PubMed ID: 21958512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractal characteristics of May-Grünwald-Giemsa stained chromatin are independent prognostic factors for survival in multiple myeloma.
    Ferro DP; Falconi MA; Adam RL; Ortega MM; Lima CP; de Souza CA; Lorand-Metze I; Metze K
    PLoS One; 2011; 6(6):e20706. PubMed ID: 21698234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches.
    Chopra A; Pati H; Mahapatra M; Mishra P; Seth T; Kumar S; Singh S; Pandey S; Kumar R
    Ann Hematol; 2012 Sep; 91(9):1351-62. PubMed ID: 22526362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free imaging and identification of typical cells of acute myeloid leukaemia and myelodysplastic syndrome by Raman microspectroscopy.
    Vanna R; Ronchi P; Lenferink AT; Tresoldi C; Morasso C; Mehn D; Bedoni M; Picciolini S; Terstappen LW; Ciceri F; Otto C; Gramatica F
    Analyst; 2015 Feb; 140(4):1054-64. PubMed ID: 25568900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
    Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
    Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
    Baur AS; Meugé-Moraw C; Schmidt PM; Parlier V; Jotterand M; Delacrétaz F
    Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
    Mangi MH; Mufti GJ
    Blood; 1992 Jan; 79(1):198-205. PubMed ID: 1370203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome.
    Matarraz S; Teodosio C; Fernandez C; Albors M; Jara-Acevedo M; López A; Gonzalez-Gonzalez M; Gutierrez ML; Flores-Montero J; Cerveró C; Pizarro-Perea M; Paz Garrastazul M; Caballero G; Gutierrez O; Mendez GD; González-Silva M; Laranjeira P; Orfao A
    PLoS One; 2012; 7(8):e44321. PubMed ID: 22952954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative evaluation of juxtatrabecular fibrosis in myelodysplastic syndromes].
    Reissenweber N; Gualco G; Panuncio A; Díaz G
    Sangre (Barc); 1995 Dec; 40(6):479-83. PubMed ID: 8850231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.
    Arenillas L; Calvo X; Luño E; Senent L; Alonso E; Ramos F; Ardanaz MT; Pedro C; Tormo M; Marco V; Montoro J; Díez-Campelo M; Brunet S; Arrizabalaga B; Xicoy B; Andreu R; Bonanad S; Jerez A; Nomdedeu B; Ferrer A; Sanz GF; Florensa L
    J Clin Oncol; 2016 Sep; 34(27):3284-92. PubMed ID: 27382099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter comparison of CD34+ myeloid cell count by flow cytometry in low-risk myelodysplastic syndrome. Is it feasible?
    Font P; Subirá D; Matarraz S; Benavente C; Cedena MT; Morado M; Pérez Corral A; Bellón JM; Díez-Martín JL
    Cytometry B Clin Cytom; 2018 May; 94(3):527-535. PubMed ID: 28618451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
    Mufti GJ; Bennett JM; Goasguen J; Bain BJ; Baumann I; Brunning R; Cazzola M; Fenaux P; Germing U; Hellström-Lindberg E; Jinnai I; Manabe A; Matsuda A; Niemeyer CM; Sanz G; Tomonaga M; Vallespi T; Yoshimi A;
    Haematologica; 2008 Nov; 93(11):1712-7. PubMed ID: 18838480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A partial nucleated differential cell count of the bone marrow aspirate that is independent of peripheral blood dilution.
    Lee SH; Ho SJ; Thomas DT; Giri P; Lee H; Sia H; To LB; Sullivan TR
    Int J Lab Hematol; 2008 Dec; 30(6):473-9. PubMed ID: 18983299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics and chromatin texture features in acute promyelocytic leukemia.
    De Mello MR; Albuquerque DM; Pereira-Cunha FG; Albanez KB; Pagnano KB; Costa FF; Metze K; Lorand-Metze I
    Diagn Pathol; 2012 Jun; 7():75. PubMed ID: 22742960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors.
    Reis-Alves SC; Traina F; Metze K; Lorand-Metze I
    Diagn Pathol; 2015 Apr; 10():44. PubMed ID: 25924846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.